Palisade Bio (PALI) Receivables - Other (2016 - 2023)
Palisade Bio (PALI) has disclosed Receivables - Other for 7 consecutive years, with $105625.0 as the latest value for Q4 2023.
- On a quarterly basis, Receivables - Other fell 25.22% to $105625.0 in Q4 2023 year-over-year; TTM through Dec 2023 was $105625.0, a 25.22% decrease, with the full-year FY2023 number at $105625.0, down 25.22% from a year prior.
- Receivables - Other was $105625.0 for Q4 2023 at Palisade Bio, roughly flat from $105625.0 in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $229000.0 in Q1 2019 to a low of $105625.0 in Q2 2023.
- A 4-year average of $187375.0 and a median of $229000.0 in 2019 define the central range for Receivables - Other.
- Peak YoY movement for Receivables - Other: skyrocketed 267.88% in 2019, then fell 25.22% in 2023.
- Palisade Bio's Receivables - Other stood at $229000.0 in 2019, then changed by 0.0% to $229000.0 in 2020, then plummeted by 38.32% to $141250.0 in 2022, then fell by 25.22% to $105625.0 in 2023.
- Per Business Quant, the three most recent readings for PALI's Receivables - Other are $105625.0 (Q4 2023), $105625.0 (Q3 2023), and $105625.0 (Q2 2023).